Royalty Pharma plc - Ordinary Shares - Class A
RPRX
Market Cap$12.57B
Close$
$73.33
168.9% upside
Current Fair Value
168.9% upsideUndervalued by 168.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.57 Billion |
|---|---|
| Enterprise Value | $17.84 Billion |
| Dividend Yield | $0.9925 (3.56%) |
| Earnings per Share | $1.33 |
| Beta | 0.62 |
| Outstanding Shares | 450,981,030 |
| Avg 30 Day Volume | 2,912,380 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 15.74 |
|---|---|
| PEG | -15.96 |
| Price to Sales | 6.82 |
| Price to Book Ratio | 1.95 |
| Enterprise Value to Revenue | 7.97 |
| Enterprise Value to EBIT | 19.4 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 0.94 |
Revenue Sources
No data
ESG Score
No data